Literature DB >> 26250539

Cultured Mesenchymal Stem Cells Stimulate an Immune Response by Providing Immune Cells with Toll-Like Receptor 2 Ligand.

Ada Weinstock1, Meirav Pevsner-Fischer2, Ziv Porat3, Michael Selitrennik4, Dov Zipori5.   

Abstract

Mesenchymal stem cells (MSCs) serve as supporting and regulatory cells, by providing tissues with multiple factors and are also known for their immunosuppressive capabilities. Our laboratory had previously shown that MSCs expressed toll-like receptor (TLR) 2 and are activated by its ligand Pam3Cys. TLR2 is an important component of the innate immune system, as it recognizes bacterial lipopeptides, thus priming a pro-inflammatory immune response. This study showed that Pam3Cys attached extensively to cells of both wild-type and TLR2 deficient cultured MSCs, thus, independently of TLR2. The TLR2 independent binding occurred through the adsorption of the palmitoyl moieties of Pam3Cys. It was further showed that Pam3Cys was transferred from cultured MSCs to immune cells. Moreover, Pam3Cys provided to the immune cells induced a pro-inflammatory response in vitro and in vivo. Overall, it is demonstrated herein that a TLR2 ligand bound to MSCs also through a TLR2 independent mechanism. Furthermore, the ligand incorporated by MSCs is subsequently released to stimulate an immune response both in vitro and in vivo. It is thus suggested that during bacterial infection, stromal cells may retain a reservoir of the TLR2 ligands, in a long-term manner, and release them slowly to maintain an immune response.

Entities:  

Keywords:  Mesenchymal stem cells; Pam3Cys; Toll-like receptor 2

Mesh:

Substances:

Year:  2015        PMID: 26250539     DOI: 10.1007/s12015-015-9614-8

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  64 in total

Review 1.  Recognition of pathogen-associated molecular patterns by TLR family.

Authors:  Shizuo Akira; Hiroaki Hemmi
Journal:  Immunol Lett       Date:  2003-01-22       Impact factor: 3.685

2.  Toll-like receptor 2 ligands as adjuvants for human Th1 responses.

Authors:  Peter A Sieling; Woosin Chung; Baochau T Duong; Paul J Godowski; Robert L Modlin
Journal:  J Immunol       Date:  2003-01-01       Impact factor: 5.422

Review 3.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

4.  Binding of lipopeptide to CD14 induces physical proximity of CD14, TLR2 and TLR1.

Authors:  Maria Manukyan; Kathy Triantafilou; Martha Triantafilou; Alan Mackie; Nadra Nilsen; Terje Espevik; Karl-Heinz Wiesmüller; Artur J Ulmer; Holger Heine
Journal:  Eur J Immunol       Date:  2005-03       Impact factor: 5.532

5.  Evaluation of synthetic infection-enhancing lipopeptides as adjuvants for a live-attenuated canine distemper virus vaccine administered intra-nasally to ferrets.

Authors:  D Tien Nguyen; Martin Ludlow; Geert van Amerongen; Rory D de Vries; Selma Yüksel; R Joyce Verburgh; Albert D M E Osterhaus; W Paul Duprex; Rik L de Swart
Journal:  Vaccine       Date:  2012-06-21       Impact factor: 3.641

Review 6.  TLR2 - promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity.

Authors:  Ulrich Zähringer; Buko Lindner; Seiichi Inamura; Holger Heine; Christian Alexander
Journal:  Immunobiology       Date:  2008-03-28       Impact factor: 3.144

7.  Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans.

Authors:  A Vitiello; G Ishioka; H M Grey; R Rose; P Farness; R LaFond; L Yuan; F V Chisari; J Furze; R Bartholomeuz
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

8.  Divergent levels of LBP and TGFβ1 in murine MSCs lead to heterogenic response to TLR and proinflammatory cytokine activation.

Authors:  Sarit Levin; Meirav Pevsner-Fischer; Sivan Kagan; Hila Lifshitz; Ada Weinstock; Diana Gataulin; Gilgi Friedlander; Dov Zipori
Journal:  Stem Cell Rev Rep       Date:  2014-06       Impact factor: 5.739

Review 9.  A cell biological view of Toll-like receptor function: regulation through compartmentalization.

Authors:  Gregory M Barton; Jonathan C Kagan
Journal:  Nat Rev Immunol       Date:  2009-06-26       Impact factor: 53.106

10.  Impact of oxLDL on Cholesterol-Rich Membrane Rafts.

Authors:  Irena Levitan; Tzu-Pin Shentu
Journal:  J Lipids       Date:  2011-01-18
View more
  2 in total

Review 1.  Mesenchymal Stromal Cells and Toll-Like Receptor Priming: A Critical Review.

Authors:  Mehdi Najar; Mohammad Krayem; Nathalie Meuleman; Dominique Bron; Laurence Lagneaux
Journal:  Immune Netw       Date:  2017-04-20       Impact factor: 6.303

2.  Involvement of Mesenchymal Stem Cells in Oral Mucosal Bacterial Immunotherapy.

Authors:  Alberto Vázquez; Lidia M Fernández-Sevilla; Eva Jiménez; David Pérez-Cabrera; Rosa Yañez; Jose Luis Subiza; Alberto Varas; Jaris Valencia; Angeles Vicente
Journal:  Front Immunol       Date:  2020-11-19       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.